INTRODUCTIONPost-isotretinoin acne vulgaris relapse rates remain substantial, ranging from 20 to 60%.1 Given these high rates, guidelines for post-isotretinoin acne management (PIAM) are essential for maintaining treatment success and limiting…
Read More
INTRODUCTIONWe read with interest the numerous recent publications regarding adverse dermatologic events related to glucagon-like peptide-1 receptor agonists (GLP-1RA).1,2,3 We hope to highlight some additional considerations related to the use…
Read More
INTRODUCTIONA shortage of United States (US) dermatologists exists. In 2023, US dermatologist density was 3.7 per 100,000, below the suggested 4 per 100,000.1 Geographic nonuniformity of dermatology clinicians amplifies this…
Read More
INTRODUCTIONDandruff is a common skin condition affecting up to half of the world’s population. Symptoms include pruritus, inflammation, and flaking. It is thought to be in part due to microbe…
Read More
INTRODUCTIONIsotretinoin has been used to treat severe acne vulgaris since the early 1980s. Initial studies demonstrated acne improvement with dosing regimens of 0.1, 0.5, or 1.0 mg/kg daily.1,2 A decade…
Read More
INTRODUCTIONSeborrheic dermatitis is a chronic inflammatory skin condition with an estimated global prevalence of 4.38%.1 The pathophysiology is not fully elucidated, though it involves lipid secretion by sebaceous glands, Malassezia…
Read More
INTRODUCTIONThe management of acne vulgaris is difficult owing to the chronic nature of the disease and frequent relapses.1 As such, treatment duration can last for months or years.1,2 Therapeutics that…
Read More
In this issue:A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer TherapyPreventing and treating common dermatologic toxicities associated with hormonal cancer therapies is an…
Read More
INTRODUCTIONBasal and squamous cell carcinomas are the most common cancers in the United States with an alarming 80% increase in recent years.1,2 This is likely to increase as the population…
Read More
INTRODUCTIONPre-aging is a relatively new term used to describe the early, self-perceived signs of skin aging that occur in the 20s and early 30s.1 These early changes include dullness, loss…
Read More
In this issue:A Scientific Approach to Defining, Evaluating, and Treating Pre-Aging With a Cosmetic Regimen Containing a Novel Cosmetic Peptide, Acetyl Dipeptide-31 Amide (AP31)Pre-aging is a relatively new term used…
Read More
INTRODUCTIONIn Nordic European countries, the annual incidence of new cancer cases between 2018 and 2022 was 642.4 per 100,000 in males and 520.3 per 100,000 in females, with a lifetime…
Read More
